Deeper studies have claimed high expression of monocarboxylate transporter 4 (MCT4) exacerbates intestinal inflammation in patients with IBD via activation of the NLRP3 inflammasome through the ERK1/2-NF-κB axis, which initiates pyroptosis in IECs (162, 163). This evidence concerns the gene NFKB1 and inflammatory bowel disease.